Figures

The following figures are from the Dissolving Illusions 10th Anniversary Edition and the First Edition. Where applicable, “*Tenth Anniversary Edition Only” is noted. Since the chapter numbers have changed between editions, references to the First Edition are provided where needed, such as “*First Edition: Figure 5.1.”

All figures are free for anyone to use in any way they choose.


Chapter 3: Disease—A Way of Life

Figure 3.1: London listed causes of death in 1720. (Authors’ original diagram based on London Bills of Mortality) *Tenth Anniversary Edition Only

Chapter 4: Smallpox and the First Vaccine

Figure 4.1: Small Pox & The First Vaccine. (Authors’ original diagram, Graphic Art Design by Sonja Carloff) *Tenth Anniversary Edition Only

Chapter 7: Contaminated Vaccines

*First Edition Chapter 5

Figure 7.1: Connection between vaccines and foot-and-mouth disease. (Authors’ original diagram) *First Edition: Figure 5.1

Chapter 10: The Rebel Experiment

*First Edition Chapter 7

Figure 10.1: England and Wales death rate for scarlet fever, enteric fever, and smallpox 1838-1912. In addition, vaccination rate curve from 1872-1912. (C. Killick Millard, The Vaccination Question in the Light of Modern Experience: An Appeal for Reconsideration, 1914, London, p. 16.) *Tenth Anniversary Edition Only

Chapter 14: The Amazing Decline

*First Edition Chapter 11

Figure 14.1: Age- and Sex-adjusted Mortality Rates for the United States 1900-1973, Including and Excluding Eleven Major Infectious Dis­eases, Contrasted with the Proportion of the Gross National Product Expended on Medical Care. (John B. McKinlay and Sonja M. McKinlay, “The Questionable Contribution of Medical Measures to the Decline of Mortality in the United States in the Twentieth Century,” The Milbank Memorial Fund Quarterly, Health and Society, vol. 55, no. 3, summer 1977, p. 415) *First Edition: Figure 11.1

Chapter 15: The “Disappearance” of Polio

*First Edition Chapter 12

Figure 15.1: Spinal cross-section. (“The Spinal Cord,” Nursing Care for Neurological Patients, SweetHaven Publishing Services, 2006, www.free-ed.net/sweethaven/MedTech/NurseCare/NeuroNurse01.asp?iNum=4, accessed July 2013) *First Edition: Figure 12.1
Figure 15.2: Michigan polio 1958 - epidemic virus identification via fecal analysis. (G. C. Brown, “Laboratory Data on the Detroit Poliomyelitis Epidemic 1958,” Journal of the American Medical Association, vol. 172, February 20, 1960, pp. 807–812) *First Edition: Figure 12.2
Figure 15.3: Michigan polio 1958 - epidemic viral antibody changes. (G. C. Brown, “Laboratory Data on the Detroit Poliomyelitis Epidemic 1958,” Journal of the American Medical Association, vol. 172, February 20, 1960, pp. 807–812) *First Edition: Figure 12.3
Figure 15.4: Polio incidence and DDT production in the U.S. 1940-1970. (c/o Jim West, research timeline available at https://harvoa.org/polio/index.htm#indyRes; Original chart version was published in the Townsend Letter for Doctors and Patients, 2000) *First Edition: Figure 12.4
Figure 15.5: Polio morbidity. (“Polio Disease In-Short,” Centers for Disease Control and Prevention, Department of Health and Human Services, www.cdc.gov/vaccines/vpd-vac/polio/in-short-both.htm, accessed June 17, 2013) *First Edition: Figure 12.5
Figure 15.6: Paralytic poliomyelitis cases in Maryland from 1952 to 1959. (H. Ratner, “An Untold Vaccine Story,” Child and Family, vol. 21, no. 3, 1993, pp. 253–263) *First Edition: Figure 12.6
Figure 15.7: Acute Flaccid Paralysis (AFP) and Polio from 1996 to 2011. (http://apps.who.int/immunization_monitoring/en/diseases/poliomyelitis/afpextract.cfm, accessed June 2012) *First Edition: Figure 12.7
Figure 15.8: Non-Polio Acute Flaccid Paralysis (NPAFP) correlation to Oral Polio Vaccine (OPV). (http://jacob.puliyel.com/download.php?id=248, accessed December 2023) *First Edition: Figure 12.8

Chapter 16: Whooping Cough

*First Edition Chapter 13

Figure 16.1: United States pertussis incidence by year from 1980 to 2010. (“Summary of Notifiable Diseases—United States, 2009,” MMWR, vol. 58, no. 53, May 13, 2011, www.cdc.gov/mmwr/preview/mmwrhtml/mm5853a1.htm, accessed July 2013) *First Edition: Figure 13.1
Figure 16.2: New Zealand Pertussis notifications and hospitalisations, 1997–2019 (New Zealand Immunisation Handbook—15. Pertussis (whooping cough): https://www.health.govt.nz/our-work/immunisation-handbook-2020/15-pertussis-whooping-cough) *Tenth Anniversary Edition Only
Figure 16.3: Prevaccination vs. Vaccination Era. (Authors’ original diagram, Graphic Art Design by Sonja Carloff) based on information in Erik L Hewlett and Kathryn M Edward, “Clinical practice. Pertussis—not just for kids,” New England Journal of Medicine, March 24, 2005 (12), pp. 1215–1222.) *Tenth Anniversary Edition Only
Figure 16.4: The effect of vaccination or convalescence on colonization. Naïve animals, aP-vaccinated animals, wP-vaccinated animals, and previously infected (convalescent) animals were directly challenged with B. pertussis. (Authors’ original diagram based on information in Jason M. Warfel, Lindsey I. Zimmerman, and Tod J. Merkel, “Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model,” Proceedings of the National Academy of Sciences, 2013.) *Tenth Anniversary Edition Only